IOVA - Iovance Biotherapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.33B
Enterprise Value 31.22B
Trailing P/E N/A
Forward P/E 1-11.29
PEG Ratio (5 yr expected) 10.67
Price/Sales (ttm)N/A
Price/Book (mrq)7.49
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-13.26

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-35.47%
Return on Equity (ttm)-58.94%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -91.92M
Net Income Avi to Common (ttm)-92.06M
Diluted EPS (ttm)-1.41
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)145.37M
Total Cash Per Share (mrq)1.62
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)15.09
Book Value Per Share (mrq)1.99

Cash Flow Statement

Operating Cash Flow (ttm)-78.71M
Levered Free Cash Flow (ttm)-42.11M

Trading Information

Stock Price History

Beta 3.05
52-Week Change 3127.07%
S&P500 52-Week Change 313.44%
52 Week High 319.90
52 Week Low 34.45
50-Day Moving Average 316.44
200-Day Moving Average 311.96

Share Statistics

Avg Vol (3 month) 31.16M
Avg Vol (10 day) 3436.03k
Shares Outstanding 589.45M
Float 62.49M
% Held by Insiders 16.16%
% Held by Institutions 174.68%
Shares Short 32.37M
Short Ratio 34.93
Short % of Float 34.32%
Shares Short (prior month) 32.49M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/100
Last Split Date 3Sep 26, 2013